NorthShore University HealthSystem operates hospitals and medical group offices. It offers treatment for alcohol addictions and substance abuses, allergies, asthma and immunology, arthritis, cancer, cardiovascular, diabetes, psychiatry and behavioral sciences, and others. The company also provides services in the areas of dentistry, dermatology, emergency medicine, endocrinology, family medicine, gastroenterology, general surgery, home health, hospice, integrative medicine, internal medicine, interventional radiology, medical genetics, nephrology, neurology, nuclear medicine, obstetrics and gynecology, ophthalmology, orthopedic, otolaryngology, plastic surgery, vascular surgery, and women's ...
2650 Ridge Avenue
Evanston, IL 60201
Founded in 1891
NorthShore University HealthSystem Announces Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risk Assessment
Jul 18 16
Researchers at NorthShore University HealthSystem(NorthShore) have launched the first clinical trial to investigate a genetic risk score (GRS) test to predict the risk of breast, prostate and colorectal cancer in the primary care setting. The test was developed by NorthShore researcher Jianfeng Xu, DrPH, in order to provide primary care physicians with a tool to better understand how to prevent and treat cancer, and learn how patients respond after learning of increased cancer risk. The outcome of the clinical trial will inform the integration of the genetic risk score test into practice by the health system's approximately 150 primary care physicians. While evaluating patients' responses to finding out their genetic risk score for breast, colorectal and prostate cancer, the trial also examines whether patients with results that indicate increased cancer risk adhere to NorthShore's modified cancer screening guidelines. For those with an elevated cancer risk, a more intensive cancer screening plan would be discussed. The clinical trial will enroll 500 consenting patients who submitted blood samples through NorthShore's Genomic Health Initiative, a research program aiming to collect a large number of blood samples to better compare genomic information across a variety of health conditions to improve the prevention and treatment of diseases on a larger scale. Participants in the clinical trial are between 40 and 70 years of age with no prior diagnosis of colorectal, breast or prostate cancer. Results are expected in about one year. NorthShore is taking this proactive, preventive approach to healthcare with the intent to make a genetic risk score test available to all interested NorthShore patients in the future. The test will ultimately include a wider array of cancers and other diseases, as well.
NorthShore University HealthSystem Presents at Healthcare Analytics 2016, Jul-18-2016 04:30 PM
Jul 15 16
NorthShore University HealthSystem Presents at Healthcare Analytics 2016, Jul-18-2016 04:30 PM. Venue: Chicago, Illinois, United States. Speakers: Jonathan Birnberg, Associate Medical Director, Clinical Analytics.